The report gives extensive data on the pipeline items with near examination of the items at different phases of improvement. The report audits significant players included in the pipeline item advancement. It likewise gives data about clinical trials in advancement, which incorporates trial stage, trial status, trial begin and end dates, and, the quantity of trials for the key Artificial Pancreas pipeline items.